Journal
AMERICAN JOURNAL OF PSYCHIATRY
Volume 167, Issue 1, Pages 24-39Publisher
AMER PSYCHIATRIC PUBLISHING, INC
DOI: 10.1176/appi.ajp.2009.09050744
Keywords
-
Categories
Funding
- National Center for Research Resources (NCRR) [MO1-RR-00071]
- NIMH [MH62665, MH61017, MH63875, MH56140]
- National Institute of Alcoholism and Alcohol Abuse (NIAAA) [P20AA015630]
- Veterans Affairs VISN 3 Mental Illness Research, Education, and Clinical Center
- NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000071] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH056140, R01MH061017, R01MH062665, R01MH063875] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P20AA015630] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Borderline personality disorder is characterized by affective instability, impulsivity, identity diffusion, and interpersonal dysfunction. Perceived rejection and loss often serve as triggers to impulsive, suicidal, and self-injurious behavior, affective reactivity, and angry outbursts, suggesting that the attachment and affiliative system may be implicated in the disorder. Neuropeptides, including the opioids, oxytocin, and vasopressin, serve a crucial role in the regulation of affiliative behaviors and thus may be altered in borderline personality disorder. While clinical data are limited, the authors propose alternative neuropeptide models of borderline personality disorder and review relevant preclinical research supporting the role of altered neuropeptide function in this disorder in the hope of stimulating more basic research and the development of new treatment approaches.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available